DCN Dx extends a special thank you to all who joined us at the 2025 Precision Med Tri-Conference & Expo. The event provided an invaluable opportunity to connect with diagnostic developers, share expertise, and discuss strategies for navigating regulatory challenges in IVD development.
A key moment from the event was the presentation by DCN Dx’s Chief Operating Officer, Patrick Vaughan, Ph.D. His session, Regulatory Pitfalls in Dx Development: Lessons from Real-World Case Studies, provided attendees with practical insights drawn from an STI biomarker lateral flow assay case study. Dr. Vaughan explored the impact of early regulatory engagement, study design challenges, and best practices for refining assays to meet validation, scalability, and commercialization requirements.
Missed the live session? You can now watch Dr. Vaughan’s full presentation by submitting the form below:
